Your browser doesn't support javascript.
loading
Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality.
Langlais, Crystal S; Graff, Rebecca E; Van Blarigan, Erin L; Neuhaus, John M; Cowan, Janet E; Broering, Jeanette M; Carroll, Peter; Kenfield, Stacey A; Chan, June M.
Afiliação
  • Langlais CS; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA. crystal.langlais@ucsf.edu.
  • Graff RE; IQVIA, Durham, NC, USA. crystal.langlais@ucsf.edu.
  • Van Blarigan EL; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Neuhaus JM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Cowan JE; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Broering JM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Carroll P; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • Kenfield SA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Chan JM; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
Br J Cancer ; 129(2): 346-355, 2023 08.
Article em En | MEDLINE | ID: mdl-37217583
BACKGROUND: Individual behaviours are associated with prostate cancer (PC) progression. Behavioural scores, comprised of multiple risk factors, allow assessment of the combined impact of multiple behaviours. METHODS: We examined the association between six a priori scores and risk of PC progression and mortality among 2156 men with PC in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) cohort: two scores developed based on the PC survivorship literature ('2021 Score [+ Diet]'); a score developed based on pre-diagnostic PC literature ('2015 Score'); and three scores based on US recommendations for cancer prevention ('WCRF/AICR Score') and survival ('ACS Score [+ Alcohol]'). Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated for progression and PC mortality via parametric survival models (interval censoring) and Cox models, respectively. RESULTS: Over a median (IQR) of 6.4 (1.3, 13.7) years, we observed 192 progression and 73 PC mortality events. Higher (i.e., healthier) 2021 Score + Diet and WCRF/AICR Scores were inversely associated with risk of PC progression (2021 + Diet: HRcontinuous = 0.76, 95% CI: 0.63-0.90. WCRF/AICR: HRcontinuous = 0.83, 95% CI: 0.67-1.02) and mortality (2021 + Diet: HRcontinuous = 0.65, 95% CI: 0.45-0.93. WCRF/AICR: HRcontinuous = 0.71; 95% CI: 0.57-0.89). The ACS Score + Alcohol was only associated with progression (HRcontinuous = 0.89, 95% CI: 0.81-0.98) while the 2021 Score was only associated with PC mortality (HRcontinuous = 0.62, 95% CI: 0.45-0.85). The 2015 was not associated with PC progression or mortality. CONCLUSION: Findings strengthen the evidence that behavioural modifications following a prostate cancer diagnosis may improve clinical outcomes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Br J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Br J Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos